Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 10,120 | 1,698 | 6,360 | 2,330 | 1,715 |
| Cost of Goods | 11,387 | N/A | N/A | N/A | N/A |
| Gross Profit | -1,267 | 1,698 | 6,360 | 2,330 | 1,715 |
| Operating Expenses | 240,546 | 181,399 | 149,768 | 167,330 | 169,860 |
| Operating Income | -241,426 | -179,701 | -143,408 | -165,000 | -168,145 |
| Interest Expense | 9,294 | 45,067 | 8,905 | 1,105 | 0 |
| Other Income | 31,586 | 16,366 | 3,746 | 117 | 1,888 |
| Pre-tax Income | -219,134 | -208,402 | -148,567 | -165,988 | -166,257 |
| Income Tax | 1,528 | -19 | 272 | -23,892 | -24,163 |
| Net Income Continuous | -220,662 | -208,383 | -148,839 | -142,096 | -142,094 |
| Net Income | $-220,662 | $-208,383 | $-148,839 | $-142,096 | $-142,094 |
| EPS Basic Total Ops | -0.86 | -1.20 | -1.57 | -1.97 | -2.76 |
| EPS Basic Continuous Ops | -0.86 | -1.20 | -1.57 | -1.97 | -2.76 |
| EPS Diluted Total Ops | -0.86 | -1.20 | -1.57 | -1.97 | -2.76 |
| EPS Diluted Continuous Ops | -0.86 | -1.20 | -1.57 | -1.97 | -2.76 |
| EPS Diluted Before Non-Recurring Items | -0.86 | -1.20 | -1.57 | -1.97 | -2.76 |
| EBITDA(a) | $-233,710 | $-173,136 | $-135,986 | $-156,542 | $-162,487 |